Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | PGR | P06401 | 4/20 | 0.80 |
| ▸ | NR3C1 | P04150 | 8/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | AR | P10275 | 2/20 | 0.72 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.72 |
| ▸ | TNF | P01375 | 1/20 | 0.72 |
| ▸ | IL6 | P05231 | 1/20 | 0.72 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.72 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.72 |
| ▸ | GLUL | P15104 | 1/20 | 0.72 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.72 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10363483 | 1.00 | HIF1A (0.82) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL7985 | 0.98 | HIF1A (0.80) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL7142738 | 0.98 | HIF1A (0.79) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL7613021 | 0.98 | HIF1A (0.79) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL7145316 | 0.98 | HIF1A (0.79) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL11090884 | 0.98 | HIF1A (0.79) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| Prednisolone Acetate SCHEMBL9838659 | 0.97 | HIF1A (0.86) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL16018292 | 0.97 | HIF1A (0.85) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| Prednisolone Steaglate SCHEMBL136864 | 0.96 | HIF1A (0.77) | HIF1ALMNAPGRNR3C1CYP3A4 | |
| SCHEMBL11068483 | 0.96 | HIF1A (0.84) | HIF1ALMNAPGRNR3C1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120154586-A | Powder aerosol composition for inhalation, powder aerosol for inhalation, preparation method of powder aerosol for inhalation and powder aerosol for inhalation | 上海臣邦医药科技股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-118662643-A | Application of hormone medicine composition in preparation of medicine for treating osteoarthritis | 中南大学湘雅医院 | 2024-09-20 | — | — | CN | claimed |
| CN-116940197-A | Light emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116098866-A | Glucocorticoid fat emulsion for treating arthralgia, preparation method and application thereof | 中南大学湘雅医院 | 2023-05-12 | — | — | CN | claimed |
| CN-116077465-A | Nanometer preparation for joint pain relief, and preparation method and application thereof | 中南大学湘雅医院 | 2023-05-09 | — | — | CN | claimed |
| CN-116077669-A | Glucocorticoid nano-lipid carrier for treating arthralgia, preparation method and application thereof | 中南大学湘雅医院 | 2023-05-09 | — | — | CN | claimed |
| CN-114698370-A | Compounds and methods for treating cytokine release syndrome | 里格尔药品股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114685591-A | Refining method and application of C1, 2-position dehydrosteroid compound | 天津药业研究院股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| WO-2022089499-A1 | PREFERRED METHOD OF USING LEVALBUTEROL SULFATE FOR THE TREATMENT OF RESPIRATORY DISEASES | 苏州君宁新药开发中心有限公司 | 2022-05-05 | — | — | WO | claimed |
| CN-114286679-A | Methods of blocking or ameliorating cytokine release syndrome | 里格尔药品股份有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-101060831-A | Conveniently implantable sustained release pharmaceutical composition | RAMSCOR INC (US) | 2007-10-24 | — | — | CN | claimed |
| CN-1267087-C | Pharmaceutical tablet | PHARMACIA CORP (US) | 2006-08-02 | — | — | CN | claimed |
| CN-1761487-A | Dispersible formulations of anti-inflammatory agents | PHARMACIA CORP (US) | 2006-04-19 | — | — | CN | claimed |
| CN-1761486-A | Dispersible pharmaceutical composition for treating mastitis and otic disorders | PHARMACIA CORP (US) | 2006-04-19 | — | — | CN | claimed |
| CN-1630512-A | Pharmaceutical tablet | PHARMACIA CORP (US) | 2005-06-22 | — | — | CN | claimed |
| CN-1627938-A | Pharmaceutical dosage form for transmucosal delivery | PHARMACIA CORP (US) | 2005-06-15 | — | — | CN | claimed |
| CN-1433396-A | Pharmaceutical compounds | NICOX SA (FR) | 2003-07-30 | — | — | CN | claimed |
| CN-1420891-A | Pharmaceutical compounds | NICOX SA (FR) | 2003-05-28 | — | — | CN | claimed |
| US-4765983-A | INTESTINAL-SOLUBLE POLYMER AND MEDICAMENT | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1988-08-23 | — | — | US | claimed |
| US-4478818-A | Ocular preparation housing steroid in two different therapeutic forms | ALZA CORPORATION (US) | 1984-10-23 | — | — | US | claimed |